15:42 Dec 05

AstraZeneca Pharma India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
9226.50
+23.50 (+0.26%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

AstraZeneca Pharma India Ltd. Financials

AstraZeneca Pharma India Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
9226.50
+23.50 (+0.26%)
15:42 Dec 05
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

27/100
Expensive Valuation

Technical

58/100
Technically Neutral

Strength

8

Weakness

2

Opportunity

1

Threats

0

15.02 %

ROE %

7.62 %

ROA %

79.66

EPS

308.14

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
805.6 1002.97 1295.53 1716.29 1855.08
Operating Expenses +
719.42 837.85 1111.08 1462.32 1558.22
Raw Material
297.49 408.84 628.33 1295.95 1436.84
Increase Decrease in Cost
14.47 -48.86 -33.77 -332.94 -408.87
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
230.21 259.1 241.45 257.44 280.93
Miscellaneous Expenses
593.01 867.69 1273.69 2259.51 249.32
Operating Profit
86.18 165.12 184.45 253.97 296.86
Other Income
14.76 26.1 34.8 40.63 43.52
Depreciation
16.95 16.26 14.94 39.99 52.65
Interest
0.95 0.63 1.2 1.46 2.07
Profit before tax and exceptio..
83.04 174.33 203.11 253.15 285.66
Exceptional Items
0 -40.23 16.43 -96.79 -39.59
PBT
83.04 134.1 219.54 156.36 325.25
Provision for Taxation
21.44 34.81 58.03 40.62 62.86
Net Profit
61.6 99.29 161.51 115.74 183.36
NET Profit after MI
0 0 0 0 0
EPS
24.6 39.7 64.6 46.3 73.34
Operating Profit Margin (%)
10.7 16.46 14.24 14.8 16
Net Profit Margin (%)
7.65 9.9 12.47 6.74 9.88

AstraZeneca Pharma India Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 75.00 75.00 75.00 75.00 75.00 75.00
FII 2.70 3.00 2.90 2.90 2.90 2.80
Public 5.30 4.60 4.60 5.20 5.10 5.00
Others 17.00 17.40 17.50 16.90 17.00 17.20
Shareholder Shares Holding %
Download Our App On: